CTLA-4, LAG-3, Tim-3, and PD-1 receptors are transiently expressed following TCR activation [29,30,31,32] and bind to ligands expressed at the surface of tumor cells and of some immune cells (DCs, monocytes, B lymphocytes). This evidence concerns the gene HAVCR2 and neoplasm.